Plate Nº 42 · recorded October 10, 2026
Science Policy & FundingReported finding
Trump 2027 Budget Proposes $5 Billion Cut to NIH Funding
The Trump administration's fiscal 2027 budget plan would cut $5 billion from the NIH, the world's largest public biomedical research funder. STAT reports Congress is unlikely to accept the reduction.
By James Calloway3 min read609 words
In brief
- Trump's FY 2027 budget plan proposes a $5 billion cut to the National Institutes of Health
- NIH's annual appropriations have recently hovered near $47 billion; the cut would equal roughly 10 percent
- Trump's first-term administration proposed double-digit cuts to NIH starting in FY 2018, which Congress largely restored
- STAT reported that Congress is unlikely to accept the FY 2027 reduction
- STAT did not detail which NIH institutes or programs would absorb the proposed cut
The Trump administration's fiscal year 2027 budget plan would cut $5 billion from the National Institutes of Health, STAT reported, even though Congress has historically resisted reductions to the country's largest public biomedical research funder.
NIH, founded in 1887 and headquartered in Bethesda, Maryland, is the U.S. government's primary agency for biomedical and public-health research. The agency supports work on cancer, Alzheimer's disease, heart disease, infectious diseases, mental illness, and many other conditions. Most of its funding flows to universities, medical schools, and independent research institutes through competitive peer-reviewed grants.
In recent years, NIH's annual appropriations have hovered near $47 billion, making it the world's largest public funder of biomedical research. The proposed cut, if applied to current spending, would amount to roughly a 10 percent reduction.
How does the U.S. budget process shape this fight?
A presidential budget request is a non-binding statement of priorities, not law. Congress, working through the House and Senate appropriations committees, writes the spending bills that ultimately determine NIH's funding. Whatever cut the White House proposes typically becomes a starting point for negotiation rather than a final figure.
Has Congress pushed back before?
Yes. During President Trump's first term, the administration proposed double-digit percentage cuts to NIH in fiscal 2018 and again in subsequent years. Lawmakers in both parties restored most of the proposed reductions in the annual appropriations process, citing the agency's central role in supporting research that pharmaceutical companies and academic medical centers rely on for early-stage work.
House and Senate leaders from both parties have, in recent years, repeatedly voted to increase NIH's budget above the prior year's level — a track record that helps explain why congressional appropriators are again expected to push back on the 2027 proposal.
Which NIH programs would absorb the cut?
STAT's reporting did not specify which NIH institutes or programs would absorb the reduction, and the administration had not released line-item details at the time of publication. NIH's acting director and other political appointees at the Department of Health and Human Services had not publicly commented on the 2027 plan.
The impact could vary widely depending on allocation:
- New competing research grants to universities and medical schools
- Continuation of multi-year studies already in progress
- Intramural research at NIH's Bethesda campus
- Research-training programs for graduate students and postdocs
Each category typically represents a distinct share of the agency's budget. Further details from the administration would clarify which communities — academic researchers, clinicians, or trainees — would feel the reduction most directly.
Why does NIH attract unusually intense lobbying?
Few federal agencies draw as much constituent pressure as NIH. Patient-advocacy groups focused on cancer, Alzheimer's, rare diseases, and dozens of other conditions lobby intensively for higher research budgets each year. Universities and academic medical centers also press lawmakers to protect or expand funding.
That political weight has historically insulated NIH from the deepest cuts. The agency has not, however, been immune to other political pressure: the Trump administration separately moved earlier in 2025 to terminate certain NIH grants tied to vaccine hesitancy, mRNA vaccine research, and diversity, equity, and inclusion initiatives. Researchers have raised concerns about disruption to ongoing clinical trials and grant cycles.
What happens next?
Congress will write the FY 2027 appropriations bills later in 2025 and into 2026. The NIH line will be a focus of debate in both chambers. Bipartisan support for biomedical research, including among Republicans who have backed NIH increases in past years, will shape the final outcome, though the exact contours remain to be seen.
via Google News: Science Funding (Source)
More from James Calloway
Show full bio
Staff writer covering marketplaces and e-commerce at SciBeat.
205 articles
Nearby plates
- Congress's Final NIH Funding Bill Counters Trump-Era Cuts
- White House Retreats From Plan to Tighten Grip on N.I.H. Grants
- House Spending Panel Proposes Slight NIH Funding Boost for 2027
- Staffing Shortages at NIH Threaten This Year's Round of New Research Grants
- FY2027 Budget Request Proposes Billions in Science Funding Cuts